Literature DB >> 27102225

Peptide-Decorated Gold Nanoparticles as Functional Nano-Capping Agent of Mesoporous Silica Container for Targeting Drug Delivery.

Ganchao Chen1, Yusheng Xie1, Raoul Peltier1, Haipeng Lei1, Ping Wang1, Jun Chen2, Yi Hu2, Feng Wang, Xi Yao, Hongyan Sun1.   

Abstract

A stimuli-responsive drug delivery system (DDS) with bioactive surface is constructed by end-capping mesoporous silica nanoparticles (MSNs) with functional peptide-coated gold nanoparticles (GNPs). MSNs are first functionalized with acid-labile α-amide-β-carboxyl groups to carry negative charges, and then capped with positively charged GNPs that are decorated with oligo-lysine-containing peptide. The resulting hybrid delivery system exhibits endo/lysosomal pH triggered drug release, and the incorporation of RGD peptide facilitates targeting delivery to αvβ3 integrin overexpressing cancer cells. The system can serve as a platform for preparing diversified multifunctional nanocomposites using various functional inorganic nanoparticles and bioactive peptides.

Entities:  

Keywords:  charge reversal; controlled release; gold nanoparticles; peptides; targeted delivery

Mesh:

Substances:

Year:  2016        PMID: 27102225     DOI: 10.1021/acsami.6b02594

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  13 in total

Review 1.  Synthesis of gold nanomaterials and their cancer-related biomedical applications: an update.

Authors:  Saravanan Govindaraju; Kyusik Yun
Journal:  3 Biotech       Date:  2018-02-05       Impact factor: 2.406

Review 2.  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Authors:  María Vallet-Regí; Ferdi Schüth; Daniel Lozano; Montserrat Colilla; Miguel Manzano
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

Review 3.  Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.

Authors:  Rafael R Castillo; Daniel Lozano; Blanca González; Miguel Manzano; Isabel Izquierdo-Barba; María Vallet-Regí
Journal:  Expert Opin Drug Deliv       Date:  2019-04-22       Impact factor: 6.648

Review 4.  Nanoarchitectured prototypes of mesoporous silica nanoparticles for innovative biomedical applications.

Authors:  Ranjith Kumar Kankala; Ya-Hui Han; Hong-Ying Xia; Shi-Bin Wang; Ai-Zheng Chen
Journal:  J Nanobiotechnology       Date:  2022-03-12       Impact factor: 10.435

5.  Apolipoprotein E3-mediated cellular uptake of reconstituted high-density lipoprotein bearing core 3, 10, or 17 nm hydrophobic gold nanoparticles.

Authors:  Skylar T Chuang; Young-Seok Shon; Vasanthy Narayanaswami
Journal:  Int J Nanomedicine       Date:  2017-11-27

6.  pH-Sensitive Poly(β-amino ester)s Nanocarriers Facilitate the Inhibition of Drug Resistance in Breast Cancer Cells.

Authors:  Mengxue Zhou; Xingcai Zhang; Jin Xie; Rongxiang Qi; Huiru Lu; Stefano Leporatti; Jun Chen; Yi Hu
Journal:  Nanomaterials (Basel)       Date:  2018-11-19       Impact factor: 5.076

7.  pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.

Authors:  He Huang; Da-Peng Yang; Minghuan Liu; Xiangsheng Wang; Zhiyong Zhang; Guangdong Zhou; Wei Liu; Yilin Cao; Wen Jie Zhang; Xiansong Wang
Journal:  Int J Nanomedicine       Date:  2017-04-06

Review 8.  Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications.

Authors:  Wei Wu; Li Luo; Yi Wang; Qi Wu; Han-Bin Dai; Jian-Shu Li; Colm Durkan; Nan Wang; Gui-Xue Wang
Journal:  Theranostics       Date:  2018-04-30       Impact factor: 11.556

9.  Non-Covalent Loading of Anti-Cancer Doxorubicin by Modularizable Peptide Self-Assemblies for a Nanoscale Drug Carrier.

Authors:  Kin-Ya Tomizaki; Kohei Kishioka; Shunsuke Kataoka; Makoto Miyatani; Takuya Ikeda; Mami Komada; Takahito Imai; Kenji Usui
Journal:  Molecules       Date:  2017-11-06       Impact factor: 4.411

10.  A Tunable Nanoplatform of Nanogold Functionalised with Angiogenin Peptides for Anti-Angiogenic Therapy of Brain Tumours.

Authors:  Irina Naletova; Lorena Maria Cucci; Floriana D'Angeli; Carmelina Daniela Anfuso; Antonio Magrì; Diego La Mendola; Gabriella Lupo; Cristina Satriano
Journal:  Cancers (Basel)       Date:  2019-09-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.